Ask the Experts: Optimizing Cotreatment of HCV and HIV Infection

Listen as expert faculty answer clinicians’ questions about specific challenges in managing HCV/HIV coinfection, including how to apply guideline-based strategies, avoid common DAA and ART interactions, incorporate recent therapy approvals, and more.
Susanna Naggie, MD, MHS
Format: Audio (.mp3)
File Size: 3.7 MB
Released: September 13, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an independent educational grant from
Gilead Sciences

Related Content

Download free expert-authored slides on the clinical interplay of HCV and COVID-19 coinfection and the impact of the COVID-19 pandemic on access to HCV care and treatment

Ricardo Franco, MD Stacey Trooskin, MD, PhD Released: October 7, 2020

Gain experts insight with this CCO commentary on key hepatitis C elimination studies presented at the Digital International Liver Conference 2020

Nancy Reau, MD Released: October 2, 2020

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue